|
 Program
Plans for the 7th International Conference of the Society are advancing apace, with the provisional program now being released, as seen below.
We look forward to meeting you 9-11 December 2013 in Kobe, Japan under the chairmanship of Professor Akio Inui.
7th Cachexia Conference, Kobe/Japan
9-11 December 2013
Provisional
Monday 9 December 2013
12:15-13:15
Lunch seminar(s)
13:30-15.30
A - OPENING SESSION: Muscle Wasting – Assessment & Epidemiology
Welcome: Akio Inui, Stefan Anker
1. “Hippocrates” clinical science key note lecture:
Assessing muscle mass – brief history and state of the art.
Stephen Heymsfield (Baton Rouge, LA / USA)
(30 min)
2. Muscle mass and survival: the epidemiologic viewpoint
Kam Kalantar-Zadeh (Los Angeles, CA / USA)
(18 min)
3. Psychosocial effect of cachexia
Jane Hopkinson (Cardiff / UK)
(18 min)
4. Frailty: international consensus and its role in sarcopenia and cachexia
John E Morley (St. Louis, MO / USA)
(18 min)
5. The obesity paradox in 2013 – the stroke example
Wolfram Doehner (Berlin / GER)
(18 min)
15:30-16:00
Coffee break
16:00-17:45
B - PLENARY SESSION: Muscle Wasting – New Therapeutic Approaches
6. “Prometheus” basic science key note lecture:
Ghrelin – from discovery to therapy.
Dr. Masayasu Kojima (Kurume / Japan)
(30 min)
7. Targeting MIC-1/GDF1
Samuel Breit (Sydney / AUS)
(18 min)
8. Parabiosis and muscle stem cell biology
(18 min)
9. Muscle regeneration & miRNAs
Thomas Thum (Hannover / DE)
(18 min)
10. Repair of traumatic muscle damage
Steve Badylak (Pittsburgh, PA / USA)
(18 min)
18:00-19:15
Welcome reception (poster area)
Tuesday 10 December 2013
7:15-8:15
Morning symposia
8:30-10:00
C - Clinical track: Skeletal muscle mass & chronic illness
11. New methods to assess skeletal muscle mass changes
William Evans (Research Triangle Park, NC / USA)
(18 min)
12. The interface between fat and muscle in late life sarcopenia & cachexia
Tamara Harris (Bethesda, MD / USA)
(18 min)
13. Cachexia in CHF and COPD: similarities and differences
Annemie Schols (Maastricht / NL)
(18 min)
14. Respiratory muscles mass and function & COPD exacerbation
Mike Polkey (London / UK)
(18 min)
15. Muscle wasting, exercise and hip fracture
Maria Fiatarone Singh (Sydney / Australia)
(18 min)
16. Biomarkers for skeletal muscle wasting – international consensus
Matteo Cesari (Toulouse / France)
(18 min)
8:30-10:00
D - Basic track: from food intake to ghrelin and sarcopenia
17. Alterations in the Ghrelin/NPY axis in anorexia and cachexia.
Herbert Herzog (Sydney / Australia)
(18 min)
18. Etanercept for cachexia in rheumatoid arthritis: roles of gut hormones and leptin.
Chih-Yen Chen (Taipei / Taiwan)
(18 min)
19. The herbal medicine rikkunshito in cancer anorexia-cachexia: impact on survival and relationship to ghrelin signaling.
Dr. Akihiro Asakawa (Kagoshima / Japan)
(18 min)
20. Modulation of hunger and satiety peptide activity by plasma immunoglobulins
Serguei Fetissov (Rouen / France)
(18 min)
21. Sarcopenic obesity
Dr. Kyung Mook Choi (Seoul / Korea)
(18 min)
10:00-11:00
Coffee break and poster session 1 (10:10-10:50, i.e. 10 posters x 4 min)
11:00-12:30
E - Basic track: Muscle basic science
22. GWAS in sarcopenia and cachexia reserach – state of affaires in 2013.
(15 min)
23. The mitochondrial contribution to muscle atrophy in aging and disease
(15 min)
24. Ca dynamic and RYR receptors
(15 min)
25. Proteolysis mechanisms – an update
Didier Attaix (Clermont-Ferrand / France)
(15 min)
26. Muscle and non-muscle tissue interactions in cachexia: the role of inflammation.
Josep Argiles (Barcelona / ESP)
(15 min)
27. Panel discussion “Perspectives of research”
Chairs and speakers
(15 min)
11:00-12:30
F - Clinical track: Oncology and cancer cachexia – ASCO joint session (???)
28. Impact of cancer cachexia on oncology outcomes and anticancer treatment.
Florian Strasser (St. Gallen / SUI)
(18 min)
29. Multi-modal therapy for a multimodal problem: the MENAC study
Ken Fearon (Edinburgh / UK)
(18 min)
30. Diagnostic criteria of cancer cachexia: a critical evaluation
Vickie Baracos (Edmonton / CAN)
(18 min)
31. Cardiovascular problems and autonomic dysfunction in cancer cachexia.
Jochen Springer (Berlin / GER)
(18 min)
32. Nutritional intervention in cancer cachexia
Nicolaas Deutz (College Station, TX / USA)
(18 min)
12:45-13:45
Lunch seminar(s)
14:00-15:30
G - Clinical Track: Drug treatment options and results update
33. SARMs
(15 min)
34. Growth hormone + IGF-I
(15 min)
35. Ghrelin
(15 min)
36. Targeting myostatin & activin receptors
(15 min)
37. Novel beta-blockers
Stefan Anker (Berlin / GER)
(15 min)
38. Panel discussion
Chairs, experts and speakers
(15 min)
14:00-15:30
H - JUDGES’ CHOICE:
Rapid fire basic science (10-15 abstracts)
(rapid oral presentations (6-9 mins depending on number); to be chosen from the submitted abstracts – they highlight selected posters and focus on key results & messages)
Presentations will be selected from submitted abstracts.
15:30-16:30
Coffee break and poster session 2 (15:40-16:20, i.e. 10 posters x 4 min)
16:30-18:00
I - Clinical science track: Late breaking clinical trial and biomarker research
(to be chosen from the submitted abstracts and specific requests)
Presentations will be selected from submitted LBT abstracts.
16:30-18:00
K Basic track: Metabolic syndrome, biomarkers and body wasting
39. Cachexia in chronic kidney disease
Robert Mak (La Jolla, CA / USA)
(18 min)
40. Muscle wasting in diabetes
Antonio Zorzano (Barcelona / ESP)
(18 min)
41. Diabetes mellitus and muscle wasting
Seok Won Park (Seoul / Korea)
(18 min)
42. New biomarkers for skeletal muscle wasting in chronic illness
Stephan von Haehling (Berlin / GER)
(18 min)
43. Brown fat in cachexia
Graham Robertson (Concord / AUS)
(18 min)
19:30
Conference dinner
Wednesday 11 December 2011
8:00-9:30
L - Young investigators Award Session – Clinical & Basic
(Finalists: 3 abstracts clinical / 3 abstracts basic)
Presentations will be selected from submitted abstract.
8:00-9:30
M - Clinical & basic track: Food intake, appetite and nutrition
44. Effects of melatonin on appetite and other symptoms in cancer cachexia
Egidio Del Fabbro (Richmond, VA / USA)
(18 min)
45. Screening questionnaires for malnutrition and sarcopenia
Ted Malmstrom (St. Louis, MO / USA)
(18 min)
46. Mechanisms of anorexia
Johan Ruud (Linköping, Sweden)
(18 min)
47. Anorexia and quality of life.
Alessandro Laviano (Rome / ITA)
(18 min)
48. Nutrition in drug trials – problems & opportunities
Juergen Bauer (Nuremberg / Germany)
(18 min)
9:30-10:30
Coffee break and poster session 3 (9:40-10:20, i.e. 10 x 4 min)
10:30-12:00
N - JUDGES’ CHOICE: Rapid fire clinical & nutrition science (10-15 abstracts)
(rapid oral presentations (6-9 mins depending on number); to be chosen from the submitted abstracts – they highlight selected posters and focus on key results & messages)
Remote monitoring of body weight, fluid status and physical activity: telemedicine for cachexia & sarcopenia?!
Friedrich Koehler (Berlin / Germany)
Presentations will be selected from submitted abstracts.
10:30-12:00
O - Basic track: Central mechanisms of cachexia
49. Rodent models of cachexia: predict power for clinical trials
Daniel Marks (Portland, OR / USA)
(18 min)
50. The role of the brain stem: autonomic dysfunction
Massimo Piepoli (Piacenza / ITA)
(18 min)
51. Central mechanisms of fatigue
(18 min)
52. Abnormal reflex systems in cachexia
Ewa Jankowska (Wroclaw / POL)
(18 min)
53. CNS contribution to muscle atrophy and the plasticity of motor units.
(18 min)
12:15-13:15
Lunch seminar(s)
13:30-15:00
P - PLENARY SESSION: Developing therapies for cachexia & sarcopenia
54. The role of blood based biomarkers for muscle wasting treatment trials
(15 min)
55. Why are so many companies studying inclusion body myositis?
(15 min)
56. What should usual care for nutrition be in cachexia trials?
Aminah Jatoi (Rochester, MI / USA)
(15 min)
57. What are approvable endpoints in cachexia & sarcopenia?
Stefan Anker (Berlin / GER)
(15 min)
58. The regulators comments – 1
(5 min)
59. The regulators comments
(5 min)
60. Pannel discussion
Chairs, speaker, experts
(20 min)
15:00-15:30
Coffee break
15:30-16:30
Q - PLENARY SESSION: Highlights
Chaired by: V Baracos
K Kalantar-Zadeh
61. Basic Science
Denis Guttridge (Columbus, OH / USA)
(15 min)
62. Sarcopenia
Mitja Lainscak (Golnik / Slovenia)
(15 min)
63. Nutritional Therapies
(15 min)
64. Treatment of cachexia
Andrew Coats (Melbourne / Australia)
(15 min)
Awards Ceremony
Poster Award |
|
7th International Conference of the Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD)
Kobe, Japan
9-11 December 2013
Contact:
Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD)
C/O MedEd Global Solutions
75, rue Guy Môquet
92240 Malakoff
France
Phone: (+33) 1 42 53 03 03
Fax: (+33) 1 42 53 03 02
Email: SCWD@mededgs.com |
|
Full Program,
